Literature DB >> 32200022

Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.

Elizabeth L Lin1, Gary S Gottesman2, William H McAlister3, Vinieth N Bijanki4, Karen E Mack5, Donna M Griffin6, Steven Mumm7, Michael P Whyte8.   

Abstract

Hypophosphatasia (HPP) is the metabolic bone disease caused by loss-of-function mutation(s) of the ALPL gene that encodes the cell-surface tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). In HPP, extracellular accumulation of inorganic pyrophosphate (PPi), a TNSALP natural substrate and inhibitor of biomineralization, often leads to rickets or osteomalacia despite normal or sometimes elevated circulating levels of calcium (Ca) and inorganic phosphate (Pi). We report an infant girl with vitamin D deficiency rickets subsequently healed by cholecalciferol administration alone before receiving TNSALP-replacement therapy for accompanying HPP. Throughout her clinical course, circulating Ca and Pi levels were normal or elevated. At presentation with failure-to-thrive at age six months, radiographs revealed severe rickets and serum 25(OH)D was 8 ng/mL (Nl, 30-100), yet low ALP activity 55 U/L (Nl, 124-341), normal Ca 9.3 mg/dL (Nl, 8.5-10.1) and Pi 6.4 mg/dL (Nl, 3.5-7.0), and low-normal parathyroid hormone 21 pg/mL (Nl, 14-72) were instead consistent with HPP. At age nine months, after 1000 IU of cholecalciferol orally each day for six weeks, serum 25(OH)D was 86 ng/mL, strength markedly better, and radiographs documented significant improvement of rickets. At age 18 months, with fully healed vitamin D deficiency rickets, findings of underlying HPP included a waddling gait and Gower sign, metaphyseal "tongues" of radiolucency, elevated serum pyridoxal 5'-phosphate 121 ng/mL (Nl, 2-33), and bi-allelic ALPL missense mutations. Then, nearly complete restoration of strength and radiographic healing of her remaining skeletal disease from HPP occurred during asfotase alfa enzyme replacement treatment. At no time, including presentation, were circulating Ca or Pi levels compromised. Instead, and in keeping with HPP, high-normal or elevated serum Ca and Pi concentrations were consistently documented. Thus, our findings suggest some role for vitamin D in musculoskeletal health beyond assuring circulating mineral sufficiency.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  25-hydroxyvitamin D; Alkaline phosphatase; Asfotase alfa; Calcium; Cholecalciferol; Hyperphosphatemia; Hypovitaminosis D; Inorganic pyrophosphate; Mineralization; Myopathy; Osteomalacia; Phosphate; Phosphorus; Vitamin B(6)

Mesh:

Substances:

Year:  2020        PMID: 32200022     DOI: 10.1016/j.bone.2020.115322

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

Review 1.  Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.

Authors:  Andrea Trombetti; Nasser Al-Daghri; Maria Luisa Brandi; Jorge B Cannata-Andía; Etienne Cavalier; Manju Chandran; Catherine Chaussain; Lucia Cipullo; Cyrus Cooper; Dieter Haffner; Pol Harvengt; Nicholas C Harvey; Muhammad Kassim Javaid; Famida Jiwa; John A Kanis; Andrea Laslop; Michaël R Laurent; Agnès Linglart; Andréa Marques; Gabriel T Mindler; Salvatore Minisola; María Concepción Prieto Yerro; Mario Miguel Rosa; Lothar Seefried; Mila Vlaskovska; María Belén Zanchetta; René Rizzoli
Journal:  Nat Rev Endocrinol       Date:  2022-04-28       Impact factor: 43.330

Review 2.  Hormonal regulation of biomineralization.

Authors:  Andrew Arnold; Elaine Dennison; Christopher S Kovacs; Michael Mannstadt; René Rizzoli; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-03-16       Impact factor: 43.330

3.  A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia.

Authors:  Yohei Sugiyama; Taijiro Watanabe; Makiko Tajika; Tetsuro Matsuhashi; Masaru Shimura; Takuya Fushimi; Keiko Ichimoto; Ayako Matsunaga; Tomohiro Ebihara; Tomoko Tsuruoka; Tomoyuki Akiyama; Kei Murayama
Journal:  Orphanet J Rare Dis       Date:  2022-02-23       Impact factor: 4.123

Review 4.  Interactions between FGF23 and vitamin D.

Authors:  Mohammed S Razzaque
Journal:  Endocr Connect       Date:  2022-09-26       Impact factor: 3.221

Review 5.  Vitamin D supplementation: upper limit for safety revisited?

Authors:  René Rizzoli
Journal:  Aging Clin Exp Res       Date:  2020-08-28       Impact factor: 3.636

6.  Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?

Authors:  L Masi; F Marini; F Franceschelli; G Leoncini; L Cianferotti; F Cioppi; F Giusti; G Marcucci; G Gronchi; M L Brandi
Journal:  Osteoporos Int       Date:  2021-06-07       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.